Pulmonary Hypertension in Portugal: First Data from a Nationwide Registry

Table 4

Conventional therapies at baseline and follow-up of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) patients.

	Total		PAH		CTEPH
	Baseline	Follow-up	Baseline	Follow-up	Baseline	Follow-up
Diuretics	33 (41.8%)	40 (65.6%)	15 (32.6%)	17 (60.7%)	18 (54.5%)	23 (69.7%)
Digoxin	13 (16.5%)	18 (2.8%)	7 (15.2%)	11 (23.9%)	6 (18.2%)	7 (21.2%)
Oxygen	21 (26.6%)	25 (31.6%)	9 (19.6%)	12 (26.1%)	12 (36.4%)	13 (39.4%)
Warfarin	34 (43.0%)	59 (74.7%)*	10 (21.7%)	28 (60.9%)*	24 (72.7%)	31 (93.9%)*

^∗𝑃<0.001 versus baseline.